Merck pours $400M into flea drugs for Fido; Avrobio shows durability; Rhythm gets priority review
→ Merck has found its newest $400 million, just don’t expect to ever personally receive a drug from it. The NJ-based pharma giant has …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
